Open access peer-reviewed chapter

Novel Techniques in Histologic Research: Morphometry and Mass Spectrometry Imaging

Written By

Tatsuaki Tsuruyama and Takuya Hieatsuka

Submitted: 20 May 2018 Reviewed: 27 August 2018 Published: 05 November 2018

DOI: 10.5772/intechopen.81158

From the Edited Volume

Histology

Edited by Thomas Heinbockel and Vonnie D.C. Shields

Chapter metrics overview

1,107 Chapter Downloads

View Full Metrics

Abstract

Application of mass spectrometry (MS) has recently been developed for the identification of biomarkers using pathologic samples, whereas its application using formaldehyde-fixed paraffin-embedded (FFPE) tissues remains limited. In this review, we introduce MS imaging (MSI) using FFPE tissue. This method is still challenging for peptide ionization, and various pretreatment techniques have been conducted for enhancing the ionization signal of peptides. A simple chemical pretreatment method involving heating in acetonitrile-containing buffer under pressurized conditions is introduced. Further, two-dimensional MSI data are summarized in a DM for region of interest (ROI) and hierarchical cluster analyses. These techniques enable MALDI-MSI analysis of archived pathological FFPE samples to identify new biomarkers.

Keywords

  • mass spectrometry imaging
  • formalin-fixed paraffin-embedded (FFPE) tissues
  • acute myocardial infarction

1. Introduction

Over the past several decades, MS-based techniques are used in blood and urine analyses; however, their application to tissue analysis requires further development. Recently, matrix-assisted laser desorption/ionization (MALDI) has been applied for MS analysis for the identification of diagnostic markers [1, 2, 3, 4]. As one of the applications of MALDI-MS (mass spectrometry), MALDI-MS imaging (MALDI-MSI) has been recently developed for the identification of phospholipids [5, 6] and peptides [7, 8, 9, 10] and pharmacological monitoring for drug delivery system in various tissues using frozen samples [11, 12, 13]. Further, the MSI technique has been further developed in the use of formalin-fixed paraffin-embedded (FFPE) tissues and cells [7, 8, 9, 10]. Thus, this new strategies and analytical methods are useful for the study of drug pharmacokinetics, metabolism, discovery of biomarkers, and treatment-specific effects on the proteome.

1.1. Tissue pretreatment of FFPE for MS imaging

Most of human tissues are preserved as FFPE samples in bioresource repositories. Formaldehyde reacts amino acid residues such as arginine containing amino group by methylene bridging for prevention of decomposition. There are a number of reports discussing procedures for pretreatment of FFPE sections for MALDI-MS [14, 15]. Researchers performed microdissection of pathologically diagnosed disease regions, followed by protein extraction and digestion of frozen samples for proteomic study using MS technique, but this technique is costly and time-consuming for storage of frozen samples. For broad application with the use of FFPE, there is a critical issue for study using MS technique, because the methylene bridge between amino acid residues makes it difficult to ionize peptides in samples. In fact, for immunohistochemical analysis of pathological samples, FFPE tissues are subjected to a retrieval protocol, including protein digestion by proteinase, microwave, or boiling treatment. Although the treatment using detergents is available for the retrieval of FFPE, this procedure may cause noise in the MS spectrum. There are some reports that surfactants improved MS sensitivity, but there is considerable limits regarding the subjects and the amounts to use for stable protocol [16]. In addition, enzymatic digestion is generally used to promote ionization by fragmentation; however, this enzymatic digestion is not sufficient to ionization for gaining intense MS signals. In general, collagens and elastin are commonly rich in most of all tissues, and these caused background noise of MS imaging and LC–MS. Angel et al. described availability of a matrix metalloproteinase (MMP) enzymes to access [17]. PAXgene, a type of alcohol-based non–cross-linking tissue fixative, can be used as an alternative fixative for multiomic tissue analysis [18].

A simple in situ histologic pretreatment technique for FFPE sections was developed for MALDI/TOF-MS imaging. Application of immunohistochemical method such as heating sample slides in a solution of ethylenediaminetetraacetic acid (EDTA) or citric acid may be available for enhancement of signal intensity [7]. Ronci et al. reported the imaging of human lens using this method. MALDI-MSI revealed a concentric distribution pattern of proteins of apolipoprotein E (ApoE) and collagen IV alpha-1 on the anterior surface of surgically removed lens capsule [19, 20].

1.2. MALDI-MSI of acute myocardial infarction (AMI)

Next, let us review a method for the identification of molecular markers to precisely identify mitochondrial and sarcomeric proteins in cardiac tissues. Ischemic heart failure remains a major cause of sudden cardiac death. MSI is a promising technique for understanding the pathogenesis of lethal acute myocardial infarction (AMI). MSI of cardiac tissue was recently reported by several groups including these authors [21, 22].

Histological analysis is certainly one of the key methods employed in cardiac muscle damage studies. Chronic cardiac infarcted lesions demonstrate gross fibrosis, and scarring; however, acute cardiac infarcted lesions rarely include such distinct histologic and macroscopic changes. However, the microscopic findings observed in AMI are not sufficiently informative of the phase immediately following the onset of the infarction episode [23]. Of course, wavy fibers and contraction bands are histological hallmarks of myocardial injury [24], but these indicators are localized and not necessarily obvious. Depleted H-FABP staining could be seen in areas that normally show hematoxylin-eosin (H&E) staining [25].

Therefore, it is often difficult to diagnose AMI on autopsy for pathologist. In macroscopic findings in the autopsied heart, it is known that dark mottling is detectable within 4 h after the onset but variable by cases. A yellow tan may be detectable on damaged tissue within a few days. Transient thrombus in acute coronary syndrome (ACS) with coronary spasm is frequently lost. Thus, macroscopic findings are limited and not sufficiently informative at the phase immediately after the onset of the infarction episode. Therefore, evaluating the range of the infarction histologically remains difficult. Rather than these pathologic findings, a guideline for ECG has been recently developed for diagnosis of ACS [26, 27], such as ST-elevation and/or Q-wave, which is diagnostic data as well as chest pain or other pains on the onset of the infarction or other symptoms. Further, several studies have used ischemic models that facilitate a deeper understanding of cardiac muscular remodeling after hypoxic stress [28, 29]. Biochemical data of creatine kinase MB (CK-MB) is an alternative important diagnostic indicator. In clinical diagnosis, troponins [30] have been utilized for blood test. Serum markers are sensitive to time-dependent myocardial damage that is mainly caused by disruption of coronary artery blood flow. Heart-type fatty acid-binding protein (H-FABP) [31] is in clinical use, but their sustainability and sensitivity are insufficient (Table 1). Several studies have used ischemic models that facilitate a deeper understanding of cardiac muscular remodeling after hypoxic stress for identification of alternative markers [28, 29].

<2 h2–4 h4–6 h6–12 h12–24 h24–72 h72 h<
MyoglobinΔ×
H-FABPΔ×
Cardiac troponin×Δ
CK-MB×ΔΔ×
Myosin light chain×Δ

Table 1.

Representative biomarkers of AMI. CK, creatine kinase.

1.3. Laser-captured microdissection and proteomics

Liquid chromatography (LC)-MS techniques using laser microdissection technique were useful for identification of a promising biomarker for myocardial infraction [32].

In this process, contraction band and wavy fibers are hallmarks of AMI for dissection, which are localized in the infracted area. In collection of cardiac tissues, fibrotic area was excluded to prevent contaminating other types of injury. To extract proteins followed by liquid chromatography-mass spectrometry (LC–MS), each microdissected sample was suspended in NH4HCO3 containing CH3CN. Tubes were heated at 95°C and cooling trypsin digestion was performed. Tubes were incubated at 37°C overnight and then heated at 95°C. After drying, samples were resuspended in trifluoroacetic acid CH3CN. Following this process, 1.0 × 104 peptides and 102–3 proteins are identified. The list of identified proteins is shown below (Table 2). An example of spectrum in LC-MS is shown in Figure 1.

Collagen α-1 (I) chain
Collagen α-1 (III) chain
Filamin-C
Serum albumin
Hemoglobin subunit-β
Collagen α-2 (I) chain
Hemoglobin subunit-α
Keratin, type II cytoskeletal

Table 2.

Nonspecific proteins in analysis of cardiac myocyte proteins in LC-MS using FFPE. These are commonly detected proteins of various organs that should be removed from protein filing.

Figure 1.

An example of LC-MS spectrum representing hemoglobin beta in AMI and control.

1.4. MALDI-MSI and ROI analysis

The permeability of reaction buffer into FFPE tissues for hydrophilization has recently been improved such usability without tissue damage. The procedure enhances the crystallization of the peptide and matrix and organic low weight molecule, such as DHB, for MALDI/TOF-MS analysis. Here, let us review a method for the identification of molecular markers using MSI and tandem MS [6]. In detail, the tissue was incubated for 1 h at 37°C in the buffer containing NH4HCO3 and CH3CN. After removal of the buffer, the tissue was incubated again with a volume of buffer to cover the sample. The slide is subsequently covered with a cover glass and heated at 94°C on an aluminum hot plate. Next, trypsin solution is added on the tissue for protein digestion, and the slide is incubated at 37°C overnight (Figure 1). Long-term incubation in a buffer containing CH3CN may increase in spaces between tissue fibers in cardiac tissue. The matrix (2,5-dihydroxybenzoic acid, DHB) solution (Figure 2), which is known to be suitable for analysis of peptides, is deposited in droplets at a spatial interval using several devices that were developed for matrix deposition (Figure 2). After drying, mass spectra were gained using a MALDI TOF/TOF mass spectrometer equipped with a nitrogen laser. Using this method, histone H2A was reported as a marker of colon cancer [6].

Figure 2.

DHB in a solution of 50% methanol was deposited onto the sections using a piezoelectric head.

MALDI-MSI of hemoglobin beta demonstrates the two-dimensional distribution of blood flow in the cardiac tissue (Figure 3). Imaging MS Solution is a novel tool for ROI that was developed (Shimadzu Co. Ltd).

Figure 3.

Available matrix for ionization of peptide.

Using this program, the intensity in individual measured point pixels is summarized in a DM that is used for computation (Figure 4). For this analysis, the observations are based upon PTAH and H&E staining; the endocardial area is selected as ROI, in which contraction bands, dilated arterioles, and endothelial damage are observed. In this way, ROI analysis is performed to test for intensity differences between infarcted ROI and healthy area in each batch of imaging data over all pixels. ROI analyses distinguished molecules that are specific to ROI (Figures 5 and 6).

Figure 4.

Examples of comparative ROI analysis. Black bar and white bar represent the average intensity of individual m/z values. The value 1530 corresponds to hemoglobin subunit alpha. HBA signals in the infarcted ROI of samples were measured for all pixels in the respective regions (N = 4126; healthy area, N = 7554).

Figure 5.

MALDI-MSI: m/z values are 748, 795, 932, 945, 976, 1130, 1165, 1194, 1275, 1314, 1337, 1530, and 1696, respectively. The intensity is illustrated on the cardiac tissue in a heat map manner. For visualization, raw MALDI-MS data were converted into the Imaging MS Solution ver. 1.20 (Shimadzu).

Figure 6.

Examples of DM. The component (m/z)l@xij in the matrix signifies the lth m/z values (1 ≤ l ≤ k) for the pixels at the coordinate of xij (1 ≤ i ≤ m, 1 ≤ j ≤ n) on the sample issue. This DM is the platform of the ROI analysis and other static analyses. The bottom illustration represents the coordinate on the cardiac tissue (indicated by orange circles). First, we measured the intensity values for m/z = (m/z)1 of each pixel in the image and arranged the value as a column vector. Similarly, another value m/z = (m/z)2 was measured, and the value was arranged as the next column vector. Further measurements of all detected intensity values of m/z (1, 2,…l, …) are arranged in the row direction. Row and column vectors yielded a DM for a single whole dataset of a tissue.

Figure 7.

An example of HCA analysis. Distribution of hemoglobin subunit alpha peptide signal (m/z = 1529) is shown.

Note: In analysis of big imaging data, t-test is not necessarily sufficient because p-value depends on a number of data. In particular, the pixel point in ROI analyses is greater than 1000. For ROI analysis, Cohen’s d-value, which is independent of the numbers of data, supports t-test analytic data. The d-value is defined by

d=sishni1σi2+nh1σh2ni+nh2E1

si and sh represent the average signal intensity of the pixels in ROI and the control area, respectively. ni and nh represent the pixel numbers in ROI and the control, respectively. σi and σh represent the standard deviation of the intensity in the pixels ROI and the control, respectively [33]. Cohen’s criteria are as follows: d < 0.2, not significant; 0.2 < d < 0.5, small; 0.5 < d < 0.8, medium; and d > 0.8, great (significant).

1.4.1. Hierarchical cluster analysis of MSI

Imaging MS solution® (Shimadzu, Kyoto, Japan) is applied for hierarchical clustering analysis (HCA) based on the IMS data. According to the algorithm, DM clustering is performed using intensity value information for each m/z peak. When performing hierarchical cluster analysis, the Euclidean distance between data matrices was defined as performed (scalar values). We summarized the images close in distance as one larger cluster, and we then calculated the distance between the newly grouped individual clusters. By repeating this process, clustering was carried out hierarchically in the dendrogram. For HCA, we analyzed data using Ward’s method and the group average method. The vertical axis represents distance, and m/z values are represented on the horizontal axis. Comparing the distribution between hemoglobins is anticipated to provide an important data of relevance of blood flow carried by hemoglobin and mycotic injury due to infarction (Figure 7).

Advertisement

2. Conclusion

In this article, we reviewed analytical method in MSI analyses of FFPE tissues. This method for protein extraction from FFPE enabled proteomic analysis. With the combination of label-free LC-MS accompanied by precise laser microdissection enabled in situ proteomic analysis, new pathological findings are obtained.

Proteomic studies by MSI have recently been developed extensively for the identification of peptides in tissues [5, 34]. In this study, the application of MSI method leads to a significant improvement in the signal intensity FFPE tissues. The treatment improved the quality of signals obtained from FFPE specimens by swelling of the deparaffinized sample and increasing tissue permeability. For precise diagnosis, FFPE specimens provide more informatic histologic findings than frozen samples. Therefore, establishment of technique for proteomic study using FFPE contributes to the identification of novel diagnostic markers. To obtain specific markers, it is necessary to exclude nonspecific abundant proteins, including collagens, keratins, beta tubulin, and vimentin. Proteomic studies represent a promising approach to the discovery of novel diagnostic markers and understanding of the pathogenesis of cardiac remodeling. MSI may provide information about the histologic diagnosis of AMI, and several sarcomeric proteins may be a promising marker for the diagnosis of AMI. ROI and HCA analyses proved to be useful tools for the analysis of signal distribution patterns of infarcted tissues. When supplemented by these analyses, IMS may be a promising technique for the identification of biomarkers for pathological studies that involve the comparison of diseased and control areas.

Advertisement

Acknowledgments

This work was supported by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (Project No. 17013086; http://kaken.nii.ac.jp/ja/p/17013086). We thank Dr. Yu Kakimoto for providing MSI data (Figures 1 and 5).

Advertisement

Conflicts of interest

The authors have declared no conflicts of interest.

Advertisement

Appendices and nomenclature

MALDI

Matrix-assisted laser desorption ionization

MALDI-MS

MALDI mass spectrometry

MALDI-MSI

MALDI-MS imaging

FFPE

Formalin-fixed paraffin embedded

EDTA

Ethylenediaminetetraacetic acid

AMI

Acute myocardial infarction

DM

Dataset matrix

ROI

Region of interest

HCA

Hierarchical clustering analysis

References

  1. 1. Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Analytical Chemistry. 1988;60:2299-2301
  2. 2. Hillenkamp F, Karas M, Beavis RC, Chait BT. Matrix-assisted laser desorption/ionization mass spectrometry of biopolymers. Analytical Chemistry. 1991;63:1193A-1203A
  3. 3. Brown RS, Lennon JJ. Mass resolution improvement by incorporation of pulsed ion extraction in a matrix-assisted laser desorption/ionization linear time-of-flight mass spectrometer. Analytical Chemistry. 1995;67:1998-2003
  4. 4. Whittal RM, Li L. High-resolution matrix-assisted laser desorption/ionization in a linear time-of-flight mass spectrometer. Analytical Chemistry. 1995;67:1950-1954
  5. 5. Casadonte R, Caprioli RM. Proteomic analysis of formalin-fixed paraffin-embedded tissue by MALDI imaging mass spectrometry. Nature Protocols. 2011;6:1695-1709. DOI: 10.1038/nprot.2011.388
  6. 6. Kakimoto Y et al. Novel in situ pretreatment method for significantly enhancing the signal in MALDI-TOF MS of formalin-fixed paraffin-embedded tissue sections. PLoS One. 2012;7:e41607. DOI: 10.1371/journal.pone.0041607. PONE-D-12-07910 [pii]
  7. 7. Ronci M et al. Protein unlocking procedures of formalin-fixed paraffin-embedded tissues: Application to MALDI-TOF imaging MS investigations. Proteomics. 2008;8:3702-3714. DOI: 10.1002/pmic.200701143
  8. 8. Gustafsson JO, Oehler MK, McColl SR, Hoffmann P. Citric acid antigen retrieval (CAAR) for tryptic peptide imaging directly on archived formalin-fixed paraffin-embedded tissue. Journal of Proteome Research. 2010;9:4315-4328. DOI: 10.1021/pr9011766
  9. 9. Bouschen W, Schulz O, Eikel D, Spengler B. Matrix vapor deposition/recrystallization and dedicated spray preparation for high-resolution scanning microprobe matrix-assisted laser desorption/ionization imaging mass spectrometry (SMALDI-MS) of tissue and single cells. Rapid Communications in Mass Spectrometry. 2010;24:355-364. DOI: 10.1002/rcm.4401
  10. 10. Yang J, Caprioli RM. Matrix sublimation/recrystallization for imaging proteins by mass spectrometry at high spatial resolution. Analytical Chemistry. 2011;83:5728-5734. DOI: 10.1021/ac200998a
  11. 11. Kenyon CN, Melera A, Erni F. Utilization of direct liquid inlet LC/MS in studies of pharmacological and toxicological importance. Journal of Analytical Toxicology. 1981;5:216-230
  12. 12. Kim HY, Salem N Jr. A new technique for lipid analysis using liquid chromatography/mass spectrometry. Advances in Alcohol & Substance Abuse. 1988;7:241-247. DOI: 10.1300/J251v07n03_32
  13. 13. Ramseier A, Siethoff C, Caslavska J, Thormann W. Confirmation testing of amphetamines and designer drugs in human urine by capillary electrophoresis-ion trap mass spectrometry. Electrophoresis. 2000;21:380-387
  14. 14. Quanico J, Franck J, Wisztorski M, Salzet M, Fournier I. Combined MALDI mass spectrometry imaging and parafilm-assisted microdissection-based LC-MS/MS workflows in the study of the brain. Methods in Molecular Biology. 2017;1598:269-283. DOI: 10.1007/978-1-4939-6952-4_13
  15. 15. Panderi I et al. Differentiating tumor heterogeneity in formalin-fixed paraffin-embedded (FFPE) prostate adenocarcinoma tissues using principal component analysis of matrix-assisted laser desorption/ionization imaging mass spectral data. Rapid Communications in Mass Spectrometry. 2017;31:160-170. DOI: 10.1002/rcm.7776
  16. 16. Bornsen KO. Influence of salts, buffers, detergents, solvents, and matrices on MALDI-MS protein analysis in complex mixtures. Methods in Molecular Biology. 2000;146:387-404. DOI: 10.1385/1-59259-045-4:387
  17. 17. Angel PM et al. Mapping extracellular matrix proteins in formalin-fixed, paraffin-embedded tissues by MALDI imaging mass spectrometry. Journal of Proteome Research. 2018;17:635-646. DOI: 10.1021/acs.jproteome.7b00713
  18. 18. Urban C et al. PAXgene fixation enables comprehensive metabolomic and proteomic analyses of tissue specimens by MALDI MSI. Biochimica et Biophysica Acta. 2018;1862:51-60. DOI: 10.1016/j.bbagen.2017.10.005
  19. 19. Ronci M et al. MALDI-MS-imaging of whole human lens capsule. Journal of Proteome Research. 2011;10:3522-3529. DOI: 10.1021/pr200148k
  20. 20. Ronci M, Sharma S, Martin S, Craig JE, Voelcker NH. MALDI MS imaging analysis of apolipoprotein E and lysyl oxidase-like 1 in human lens capsules affected by pseudoexfoliation syndrome. Journal of Proteomics. 2013;82:27-34. DOI: 10.1016/j.jprot.2013.01.008
  21. 21. Angel PM et al. Advances in MALDI imaging mass spectrometry of proteins in cardiac tissue, including the heart valve. Biochimica et Biophysica Acta. 2017;1865:927-935. DOI: 10.1016/j.bbapap.2017.03.009
  22. 22. Yajima Y et al. Region of interest analysis using mass spectrometry imaging of mitochondrial and sarcomeric proteins in acute cardiac infarction tissue. Scientific Reports. 2018;8:7493. DOI: 10.1038/s41598-018-25817-7
  23. 23. Carbone F, Nencioni A, Mach F, Vuilleumier N, Montecucco F. Pathophysiological role of neutrophils in acute myocardial infarction. Thrombosis and Haemostasis. 2013;110:501-514. DOI: 10.1160/TH13-03-0211
  24. 24. Nakatani S et al. Left ventricular echocardiographic and histologic changes: Impact of chronic unloading by an implantable ventricular assist device. Journal of the American College of Cardiology. 1996;27:894-901
  25. 25. Meng X, Ming M, Wang E. Heart fatty acid binding protein as a marker for postmortem detection of early myocardial damage. Forensic Science International. 2006;160:11-16. DOI: 10.1016/j.forsciint.2005.08.008
  26. 26. Muller C. New ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Swiss Medical Weekly. 2012;142:w13514. DOI: 10.4414/smw.2012.13514
  27. 27. Hamm CW et al. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2011;32:2999-3054. DOI: 10.1093/eurheartj/ehr236
  28. 28. Xia P. Letter by Xia regarding article, “High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor”. Circulation. 2007;115:e393; author reply e394. DOI: 10.1161/CIRCULATIONAHA.106.667196
  29. 29. Theilmeier G et al. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation. 2006;114:1403-1409. DOI: 10.1161/CIRCULATIONAHA.105.607135
  30. 30. Tiwari RP et al. Cardiac troponins I and T: Molecular markers for early diagnosis, prognosis, and accurate triaging of patients with acute myocardial infarction. Molecular Diagnosis & Therapy. 2012;16:371-381. DOI: 10.1007/s40291-012-0011-6
  31. 31. Haltern G et al. Comparison of usefulness of heart-type fatty acid binding protein versus cardiac troponin T for diagnosis of acute myocardial infarction. The American Journal of Cardiology. 2010;105:1-9. DOI: 10.1016/j.amjcard.2009.08.645
  32. 32. Kakimoto Y et al. Sorbin and SH3 domain-containing protein 2 is released from infarcted heart in the very early phase: Proteomic analysis of cardiac tissues from patients. Journal of the American Heart Association. 2013;2:e000565. DOI: 10.1161/JAHA.113.000565
  33. 33. Jacob C. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum; 1988
  34. 34. Chatterji B, Pich A. MALDI imaging mass spectrometry and analysis of endogenous peptides. Expert Review of Proteomics. 2013;10:381-388. DOI: 10.1586/14789450.2013.814939

Written By

Tatsuaki Tsuruyama and Takuya Hieatsuka

Submitted: 20 May 2018 Reviewed: 27 August 2018 Published: 05 November 2018